Programmed Cell Death Ligand-1 (PD-L1) Expression in Gastrointestinal Stromal Tumors Correlates Significantly with Presence of Tumor Infiltrating Lymphocytes

被引：0
|
作者：
Savant, Deepika [1 ]
Vitkovski, Taisia [1 ]
Thomas, Rebecca [1 ]
Rishi, Arvind [1 ]
机构：
[1] Hofstra Northwell Hlth Sch Med, Lake Success, NY USA
来源：
LABORATORY INVESTIGATION | 2017年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
799
引用
收藏
页码：199A / 199A
页数：1
相关论文
共 50 条
  • [31] Programmed Death Ligand-1 (PD-L1) Expression in Cervical Squamous Cell Carcinoma: Does it Correlate With Outcomes?
    Monsrud, Ashley L.
    Avadhani, Vaidehi
    Mosunjac, Marina B.
    Flowers, Lisa
    Krishnamurti, Uma
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2023, 42 (06) : 535 - 543
  • [32] Programmed Death Ligand-1 (PD-L1) Expression in Squamous Cell Carcinoma from Different Anatomic Sites
    Babayeva, Sabina
    Zhang, Hongfeng
    Fanucchi, Michael
    Lafaro, Rocco
    Yusuf, Yasmin
    Fallon, John T.
    Zhong, Minghao
    MODERN PATHOLOGY, 2016, 29 : 467A - 467A
  • [33] The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor
    Brinch, Charlotte Margareta
    Hogdall, Estrid
    Junker, Niels
    Moeller, Holger Jon
    Sandfeld-Paulsen, Birgitte
    de Heer, Pieter
    Penninga, Luit
    Rossen, Philip Blach
    Krarup-Hansen, Anders
    Aggerholm-Pedersen, Ninna
    CANCERS, 2022, 14 (23)
  • [34] Increased dendritic cell (DC) expression of programmed death ligand-1 (PD-L1) mediates tolerogenic activity
    Bandyopadhyay, G.
    Li, F.
    De, A. K.
    Bankey, P.
    Lentz, C.
    Miller-Graziano, C.
    SHOCK, 2007, 27 : 5 - 5
  • [35] A NOVEL ROLE FOR PROGRAMMED CELL DEATH RECEPTOR LIGAND-1 (PD-L1) IN SEPSIS-INDUCED GASTROINTESTINAL DYSFUNCTION
    Wu, Y.
    Huang, X.
    Chung, C.
    Ayala, A.
    SHOCK, 2014, 41 : 21 - 21
  • [36] The High Expression of Programmed Death-1 Ligand-1 (PD-L1) and Its Receptor PD1 Correlates with a Poorer Prognosis In Glioblastomas
    Idoate, Miguel A.
    Arana, Inigo
    Hogeboom, Adriana
    Echeveste, Jose I.
    Lopez-Janeiro, Alvaro
    Diez-Valle, Ricardo
    Mejias Sosa, Luis D.
    Guillen, Francisco
    LABORATORY INVESTIGATION, 2016, 96 : 431A - 431A
  • [37] Combined Positive Score for Programmed Death Ligand-1 Expression and Inflammatory Microenvironment in Gastrointestinal Stromal Tumors
    Herlea, Vlad
    Rosulescu, Alexandra
    Calota, Violeta Claudia
    Croitoru, Vlad
    Stoica Mustafa, Elena
    Vasilescu, Catalin
    Alexandrescu, Sorin
    Dumitrascu, Traian
    Popescu, Irinel
    Dima, Simona Olimpia
    Sajin, Maria
    MEDICINA-LITHUANIA, 2022, 58 (02):
  • [38] Programmed Death Ligand-1 Expression on Tumor Cells in Cholangiocarcinoma Is More Frequent in Poorly Differentiated and Intrahepatic Tumors and Tumors with Brisk Tumor Infiltrating Lymphocytes
    Torbenson, Michael
    Mounajjed, Taofic
    Kipp, Benjamin R.
    McWilliams, Robert R.
    Graham, Rondell
    MODERN PATHOLOGY, 2016, 29 : 426A - 426A
  • [39] The High Expression of Programmed Death-1 Ligand-1 (PD-L1) and Its Receptor PD1 Correlates with a Poorer Prognosis In Glioblastomas
    Idoate, Miguel A.
    Arana, Inigo
    Hogeboom, Adriana
    Echeveste, Jose I.
    Lopez-Janeiro, Alvaro
    Diez-Valle, Ricardo
    Mejias Sosa, Luis D.
    Guillen, Francisco
    MODERN PATHOLOGY, 2016, 29 : 431A - 431A
  • [40] Programmed Death Ligand-1 Expression on Tumor Cells in Cholangiocarcinoma Is More Frequent in Poorly Differentiated and Intrahepatic Tumors and Tumors with Brisk Tumor Infiltrating Lymphocytes
    Torbenson, Michael
    Mounajjed, Taofic
    Kipp, Benjamin R.
    McWilliams, Robert R.
    Graham, Rondell
    LABORATORY INVESTIGATION, 2016, 96 : 426A - 426A
12345